Morning Overview on MSN
Why psoriasis can flare in the same spots, according to skin cells?
Psoriasis plaques have a stubborn habit of returning to the exact same patches of skin, even after months or years of ...
HORSHAM, Pa., Feb. 17, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative dermatologic ...
FDA approval covers adults and adolescents ≥12 years (≥88 lbs) with moderate-to-severe plaque psoriasis requiring systemic ...
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
Plaque psoriasis, also known as psoriasis vulgaris, is quite common. The condition affects approximately 1% to 2% of whites, usually presenting in the third to fourth decade of life. Men with mycosis ...
Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies Nearly 60% of adolescents treated with ICOTYDE ...
The FDA today approved icotrokinra (Icotyde; Johnson & Johnson) for the treatment of adults and pediatric patients aged 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results